Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Glob J Health Sci ; 5(6): 126-30, 2013 Sep 10.
Article in English | MEDLINE | ID: mdl-24171880

ABSTRACT

BACKGROUND: Menopause is the stage of time in which the menstruation stops following the loss of ovarian activity. The purpose of this study was to find out the effectiveness of gabapentin on hot flashes in postmenopausal women. MATERIALS & METHODS: A randomized controlled trial from Feb 2010 to 2011 was conducted. Sixty postmenopausal women who were referred to obstetrics and gynecology ward of two educational hospitals were recruited and divided into two groups (intervention and control). Intervention group received 300 mg gabapentin three times a day for three months, while control group received placebo. The Intensity and duration of hot flashes in women scored and recorded using visual analog scale. Independent, Paired t-test and chi-square test were used for analyzing data. RESULTS: Intensity of hot flashes in the beginning of research in the intervention group was significantly different with the first, second and third follow-up visit (P<0.05). Also at the end of intervention a significant difference between intervention and control groups were observed regarding the intensity, frequency and duration of hot flashes (P<0.05 and P=0.01 respectively). CONCLUSION: According to the findings of this study; it appears that the use of gabapentin could decrease the intensity, duration and frequency of hot flashes in postmenopausal women. For postmenopausal women who hormone therapy is contraindicated, gabapentine could be an acceptable alternative.


Subject(s)
Amines/therapeutic use , Anticonvulsants/therapeutic use , Cyclohexanecarboxylic Acids/therapeutic use , Hot Flashes/drug therapy , Postmenopause , gamma-Aminobutyric Acid/therapeutic use , Amines/adverse effects , Anticonvulsants/adverse effects , Cyclohexanecarboxylic Acids/adverse effects , Female , Gabapentin , Humans , Middle Aged , gamma-Aminobutyric Acid/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL